Streetbeat News

Products Services

JAGX

Jaguar Health has announced a new patent issued in Hong Kong for Napo Pharmaceuticals' Crofelemer, aimed at treating short bowel syndrome and related conditions. The company is also supporting proof-of-concept studies for rare disease indications, with results expected by the end of 2024 and 2025.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 2:07 pm

GOOG

GOOGL

Waymo, owned by Alphabet, is advancing its self-driving technology with the new 'generation 6' system, which will be integrated into Geely Zeekr electric vehicles. This technology aims to handle diverse weather conditions with fewer expensive sensors.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 2:05 pm

ADM

Farmers Business Network and ADM have launched a joint venture, Gradable, to expand a technology platform that supports sustainable and regenerative agricultural practices. This platform will help farmers and buyers meet the rising demand for sustainable farm products.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 2:04 pm

LI

NIO

XPEV

Chinese EV stocks NIO, XPeng, and Li Auto are trading higher due to China's cash-for-clunkers program, which could boost EV sales to over 10 million in 2024. Despite recent stock declines, the program's incentives may drive significant revenue growth.

Portfolio Pulse from Anusuya Lahiri

August 19, 2024 | 1:55 pm

BTCUSD

ETHUSD

Analyst Alexander Good argues that cryptocurrencies like Bitcoin and Ethereum are gaining acceptance in mainstream financial circles due to geopolitical factors and growing debt concerns. He highlights the interest from influential entities like Bloomberg and Soros Fund as indicators of this shift. Good suggests that the political risk for these cryptocurrencies is overstated, given the support from major institutional players.

Portfolio Pulse from Khyathi Dalal

August 19, 2024 | 1:43 pm

ALZN

Alzamend Neuro Inc. (NASDAQ:ALZN) stock surged after announcing a partnership with Massachusetts General Hospital for a Phase 2 study of AL001 for PTSD treatment. The study aims to assess lithium levels in the brain compared to marketed lithium salts. Alzamend hopes to meet FDA safety standards through the Section 505(b)(2) pathway.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:41 pm

BNTX

The FDA has lifted the partial clinical hold on MediLink Therapeutics' Phase 1 trial for the cancer drug BNT326/YL202, partnered with BioNTech. The trial will resume with a lower dose to ensure safety, following concerns about adverse effects at higher doses.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:39 pm

XPEV

XPeng Inc (NYSE:XPEV) is facing bearish signals ahead of its Mona M03 launch on Aug. 27, following its Q2 earnings report on Aug. 20. The stock is down over 50% YTD and is trading below key moving averages, indicating a downward trend. Analysts see a potential 26.23% upside with a price target of $9.

Portfolio Pulse from Surbhi Jain

August 19, 2024 | 1:36 pm

KSCP

Knightscope has secured two new contracts for its emergency communication devices. An Episcopal school in Southern California is expanding with an additional K1 Blue Light Tower, and Ohio healthcare clinics are upgrading existing towers with K1 Retrofit Kits.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:35 pm

TLS

Telos Corporation, an official TSA PreCheck enrollment provider, has expanded its services to eight new locations across the U.S., increasing its total to 91 centers. This expansion is part of Telos' ongoing efforts to enhance convenience for consumers by offering more enrollment centers and extended hours.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:30 pm